NovoCure Ltd (NVCR)
17.11
+0.25
(+1.48%)
USD |
NASDAQ |
Nov 21, 16:00
17.11
0.00 (0.00%)
After-Hours: 20:00
NovoCure Price to Book Value: 5.131 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 20, 2024 | 5.056 |
November 19, 2024 | 4.942 |
November 18, 2024 | 4.718 |
November 15, 2024 | 4.832 |
November 14, 2024 | 4.970 |
November 13, 2024 | 5.365 |
November 12, 2024 | 5.344 |
November 11, 2024 | 5.455 |
November 08, 2024 | 5.230 |
November 07, 2024 | 5.293 |
November 06, 2024 | 5.428 |
November 05, 2024 | 4.984 |
November 04, 2024 | 4.976 |
November 01, 2024 | 4.852 |
October 31, 2024 | 4.553 |
October 30, 2024 | 5.096 |
October 29, 2024 | 5.066 |
October 28, 2024 | 4.984 |
October 25, 2024 | 5.020 |
October 24, 2024 | 4.905 |
October 23, 2024 | 4.848 |
October 22, 2024 | 4.839 |
October 21, 2024 | 4.875 |
October 18, 2024 | 5.157 |
October 17, 2024 | 5.064 |
Date | Value |
---|---|
October 16, 2024 | 5.354 |
October 15, 2024 | 5.327 |
October 14, 2024 | 4.812 |
October 11, 2024 | 4.719 |
October 10, 2024 | 4.456 |
October 09, 2024 | 4.393 |
October 08, 2024 | 4.393 |
October 07, 2024 | 4.378 |
October 04, 2024 | 4.410 |
October 03, 2024 | 4.357 |
October 02, 2024 | 4.644 |
October 01, 2024 | 4.462 |
September 30, 2024 | 4.683 |
September 27, 2024 | 4.670 |
September 26, 2024 | 4.682 |
September 25, 2024 | 4.771 |
September 24, 2024 | 4.915 |
September 23, 2024 | 4.945 |
September 20, 2024 | 5.220 |
September 19, 2024 | 5.337 |
September 18, 2024 | 5.268 |
September 17, 2024 | 5.391 |
September 16, 2024 | 5.373 |
September 13, 2024 | 5.555 |
September 12, 2024 | 5.184 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.021
Minimum
Nov 10 2023
62.69
Maximum
Jun 23 2021
22.32
Average
19.54
Median
Price to Book Value Benchmarks
Abbott Laboratories | 5.111 |
Perspective Therapeutics Inc | 0.6153 |
Retractable Technologies Inc | 0.2154 |
Xtant Medical Holdings Inc | 1.249 |
Catheter Precision Inc | 0.2596 |
Price to Book Value Related Metrics
PS Ratio | 3.185 |
Price | 17.11 |
Earnings Yield | -8.18% |
Market Cap | 1.851B |